Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes
Segar MW, Kolkailah AA, Frederich R, et al.
Diabetes Obes Metab. Pub. online 23 May 2022.
Leggi
Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada
Marfil-Garza BA, Imes S, Verhoeff K, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00114-0.
Leggi
Reduced rate of acute diabetes events with flash glucose monitoring is sustained for two-years after initiation: extended outcomes from the RELIEF study
Riveline JP, Roussel R, Vicaut E, et al.
Diabetes Technol Ther. Pub. online 23 May 2022.
Leggi
Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study
Schwartz AV, Backlund JYC, de Boer IH, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00103-6.
Leggi
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
Karagiannis T, Avgerinos I, Liakos A, et al.
Diabetologia. Pub. online 17 May 2022.
Leggi
Direct and indirect costs of heart failure respective of diabetes status – a nationwide study
Bundgaard J, Mogensen UM, Christensen S et al
NMCD. Pub. online 19 May 2022
Leggi
FAD AMD – ANMCO – L’elettrocardiografia nel 2022: dalla teoria alla pratica clinica
Nell’ambito della collaborazione AMD – ANMCO, è stato attivato il percorso di formazione a distanza “L’elettrocardiografia nel 2022: dalla teoria alla pratica clinica”. La FAD è stata ideata allo scopo di fornire le conoscenze pratiche per la corretta esecuzione tecnica dell’ECG e sarà fruibile dal 20 giugno fino alla…
Leggi
Prevalence of vertebral fractures in adults with type 1 diabetes: DenSiFy study (Diabetes Spine Fractures)
Coll JC, Garceau E, Leslie WD, et al.
J Clin Endocrinol Metab. 2022;107(5):e1860-e1870.
Leggi